Deliang Fu

Fudan University

Papers

1

Total Citations

3

H-Index

1

About

Dr. Deliang Fu is a leading authority in the surgical oncology of the pancreas, with a particular focus on the diagnosis and treatment of pancreatic neuroendocrine neoplasms (pNENs). His work addresses the critical challenge of managing these rare, highly heterogeneous tumors, which account for roughly 3% of all pancreatic malignancies and have shown a rising global incidence. Dr. Fu’s major contribution is his leadership in developing the "Chinese Medical Association consensus for standardized diagnosis and treatment of pancreatic neuroendocrine neoplasms" (2023), a landmark guideline that establishes a unified, evidence-based framework for clinicians. This consensus, already cited 3 times since its publication, is instrumental in improving patient outcomes by standardizing surgical and medical approaches across China. Through this work, Dr. Fu has helped bridge the gap between emerging global research and practical clinical application, ensuring that complex pNEN cases receive more consistent and effective care. His efforts are shaping the next generation of pancreatic surgeons and oncologists, making him a pivotal figure in the field.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Chinese Medical Association consensus for standardized diagnosis and treatment of pancreatic neuroendocrine neoplasms
3 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 21
🏛 Institutions: Fudan University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 10 days ago